Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on December 10, 2025
December 10, 2025
Krown Technologies and ExeQuantum Announce Joint Patent for SiFA, a Breakthrough Crypto Authentication Layer Technology
Indeterminate
EIN Presswire
December 10, 2025
iCare HMO Wins 'Brand Transformation of the Year – Philippines, 2025' from the Global Brand Frontier Awards
Indeterminate
EIN Presswire
December 10, 2025
QJumpers Launches Latest AI Recruitment Module - QuickMatch AI™
Indeterminate
EIN Presswire
December 10, 2025
Infertility Drugs Market Exclusive Report with Detailed Study By 2025-2032 | Merck & Co., Inc., Ferring Pharmaceuticals
Indeterminate
EIN Presswire
December 10, 2025
Uplizd 1.0 — An End-to-End AI Application Development Platform
Indeterminate
EIN Presswire
December 10, 2025
Corrugated Packaging Market Set for Explosive Growth, Projected to Reach USD $198.8 Billion by 2031
Indeterminate
EIN Presswire
December 10, 2025
TechMatter Goes AI-First by Choosing Rinova AI and Raising the Bar for Medical Billing
Indeterminate
EIN Presswire
December 10, 2025
Unlocking the Future of Infertility Devices Market: Executive-Level Strategies By 2025-2032 | Carl Zeiss Meditec AG
Indeterminate
EIN Presswire
December 10, 2025
Chinese Neurosurgical Journal Study Provides Insights into the Role of the Brainstem in Disorders of Consciousness
Indeterminate
EIN Presswire
December 10, 2025
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
December 10, 2025
Hexaview Unveils New Methodology: Prioritizing Understanding Before Modernization
Indeterminate
EIN Presswire
December 10, 2025
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
December 10, 2025
Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
December 10, 2025
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO
Indeterminate
GlobeNewswire
December 10, 2025
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
Indeterminate
GlobeNewswire
December 10, 2025
Clearmind Medicine Announces 1-for-40 Reverse Share Split
Indeterminate
GlobeNewswire
December 10, 2025
DLH Reports Fiscal 2025 Fourth Quarter Results
Indeterminate
GlobeNewswire
December 10, 2025
Intuitive Announces Expanded Indications for da Vinci SP
Indeterminate
GlobeNewswire
December 10, 2025
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
Indeterminate
GlobeNewswire